New York State Common Retirement Fund’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Sell
120,123
-21,292
-15% -$4M 0.03% 422
2026
Q1
$27.9M Buy
141,415
+36,227
+34% +$6.99M 0.04% 337
2025
Q4
$19.3M Sell
105,188
-53,173
-34% -$9.33M 0.03% 439
2025
Q3
$24.3M Buy
158,361
+60,032
+61% +$9.09M 0.03% 385
2025
Q2
$13.7M Buy
98,329
+30,650
+45% +$4.3M 0.02% 610
2025
Q1
$9.95M Buy
67,679
+1,157
+2% +$167K 0.01% 718
2024
Q4
$8.72M Buy
66,522
+4,562
+7% +$639K 0.01% 851
2024
Q3
$9.65M Hold
61,960
0.01% 801
2024
Q2
$9.66M Buy
61,960
+32,313
+109% +$4.86M 0.01% 824
2024
Q1
$4.02M Sell
29,647
-68,635
-70% -$9.09M 0.01% 1202
2023
Q4
$13.2M Buy
98,282
+18,607
+23% +$2.42M 0.02% 706
2023
Q3
$10.8M Buy
79,675
+43,797
+122% +$5.98M 0.02% 772
2023
Q2
$5.14M Sell
35,878
-2,929
-8% -$431K 0.01% 1156
2023
Q1
$5.39M Buy
38,807
+1,999
+5% +$269K 0.01% 1132
2022
Q4
$4.99M Hold
36,808
0.01% 1179
2022
Q3
$4.04M Sell
36,808
-4,325
-11% -$549K 0.01% 1266
2022
Q2
$5.43M Buy
41,133
+12,447
+43% +$1.63M 0.01% 1157
2022
Q1
$3.81M Buy
28,686
+25,750
+877% +$3.09M ﹤0.01% 1412
2021
Q4
$342K Hold
2,936
﹤0.01% 2643
2021
Q3
$353K Buy
2,936
+625
+27% +$72.8K ﹤0.01% 2655
2021
Q2
$277K Buy
2,311
+929
+67% +$102K ﹤0.01% 2892
2021
Q1
$137K Sell
1,382
-2,557
-65% -$257K ﹤0.01% 2973
2020
Q4
$394K Buy
3,939
+951
+32% +$101K ﹤0.01% 2460
2020
Q3
$327K Hold
2,988
﹤0.01% 2427
2020
Q2
$316K Buy
2,988
+726
+32% +$75K ﹤0.01% 2443
2020
Q1
$202K Hold
2,262
﹤0.01% 2454
2019
Q4
$226K Buy
+2,262
New +$213K ﹤0.01% 2684
2017
Q4
Sell
-12,256
Closed -$830K 3083
2017
Q3
$830K Buy
+12,256
New +$774K ﹤0.01% 2097

Other funds holding AZN

New York State Common Retirement Fund's AZN Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its AstraZeneca (AZN) stake by 15% in Q2 2026, selling an estimated $4M and leaving 120,123 shares worth $22.8M. The position accounts for 0.03% of the portfolio, ranked #422.

New York State Common Retirement Fund first reported a position in AZN in Q3 2017 and has held it in 28 quarters since. The position peaked at $27.9M in Q1 2026. 700 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • New York State Common Retirement Fund held 120,123 shares of AstraZeneca worth $22.8M as of Q2 2026.
  • New York State Common Retirement Fund sold 21,292 AstraZeneca shares in Q2 2026, an estimated $4M.
  • AstraZeneca made up 0.03% of New York State Common Retirement Fund's portfolio in Q2 2026, its #422 holding.
  • New York State Common Retirement Fund first reported a position in AstraZeneca in Q3 2017 and has held it in 28 quarters since.
  • New York State Common Retirement Fund's AstraZeneca position peaked at $27.9M in Q1 2026.
  • 700 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.